Tianmu Pharmaceutical: The 2023 internal control audit report with an emphasis on matters section has no reservations, and the issues involved have been resolved

Tianmu Pharmaceutical announced that Unita Zhenqing Certified Public Accountants conducted an audit of the effectiveness of the company's internal controls over the financial report for the year 2023 and issued an internal control audit report with an unqualified opinion with an emphasis of matter paragraph. The company's board of directors now provides a special explanation regarding the matters mentioned in the emphasis of matter paragraph of the 2023 internal control audit report, indicating that the impacts have been eliminated. The company has completed the rectification of the matters involved in the internal control audit report with an unqualified opinion for the year 2023